Soma's the Retatrutide a New Metabolic Control Therapy June 24, 2026 Category: Blog Retatrutide, by Soma Chems , represents a exciting development in metabolic control . This dual-action drug combines hormonal receptor function get more info with GIP pathway stimulation , demonstrating impressive potential in patient findin read more